Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of GFRA1 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GFRA1 mRNA | affects expression | 16483693
|
D001205 |
Ascorbic Acid |
[Tretinoin co-treated with Ascorbic Acid] results in increased expression of GFRA1 mRNA | affects cotreatment|increases expression | 16443354
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of GFRA1 mRNA | increases expression | 20382639
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of GFRA1 mRNA | increases expression | 16474171
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of GFRA1 mRNA | decreases expression | 15336504
|
D003520 |
Cyclophosphamide |
GFRA1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of GFRA1 mRNA | decreases expression | 20106945
|
D004317 |
Doxorubicin |
GFRA1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of GFRA1 mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in decreased expression of GFRA1 mRNA | decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of GFRA1 mRNA | increases expression | 16474171
|
D000431 |
Ethanol |
Ethanol results in decreased expression of GFRA1 mRNA | decreases expression | 15353170
|
D005472 |
Fluorouracil |
GFRA1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D019833 |
Genistein |
Genistein results in increased expression of GFRA1 mRNA | increases expression | 16474171
|
D007657 |
Ketone Bodies |
Ketone Bodies results in decreased expression of GFRA1 mRNA | decreases expression | 16807920
|
D008701 |
Methapyrilene |
Methapyrilene results in decreased expression of GFRA1 mRNA | decreases expression | 16393664
|
D017239 |
Paclitaxel |
GFRA1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D010269 |
Paraquat |
Paraquat results in increased expression of GFRA1 mRNA | increases expression | 17077588
|
D010615 |
Phenacetin |
Phenacetin results in increased expression of GFRA1 mRNA | increases expression | 17698508
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of GFRA1 mRNA | increases expression | 19270015
|
C030299 |
phenylhydrazine |
phenylhydrazine results in increased expression of GFRA1 mRNA | increases expression | 17698508
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GFRA1 mRNA | affects binding|increases activity|increases expression | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of GFRA1 mRNA | increases expression | 18445702
|
D011078 |
Polychlorinated Biphenyls |
Polychlorinated Biphenyls analog results in increased expression of GFRA1 mRNA | increases expression | 16474171
|
D012402 |
Rotenone |
Rotenone results in decreased expression of GFRA1 mRNA | decreases expression | 19013527
|
C446685 |
systhane |
systhane results in decreased expression of GFRA1 mRNA | decreases expression | 16730040
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of GFRA1 mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of GFRA1 mRNA | decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of GFRA1 mRNA | affects binding|decreases expression | 16214954
|
D014212 |
Tretinoin |
[Tretinoin co-treated with Ascorbic Acid] results in increased expression of GFRA1 mRNA | affects cotreatment|increases expression | 16443354
|
D014212 |
Tretinoin |
[Tretinoin co-treated with SHH protein co-treated with FGF8 protein] results in increased expression of GFRA1 mRNA | affects cotreatment|increases expression | 17085092
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of GFRA1 mRNA | increases expression | 16604517
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of GFRA1 mRNA | decreases expression | 17303670
|
C032910 |
triadimefon |
triadimefon results in decreased expression of GFRA1 mRNA | decreases expression | 16730040
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
12.93 | 17676605 18926900 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
12.93 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
12.93 | 14514962 15322242 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
9.71 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
9.71 | 11192467 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.91 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
9.72 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.72 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
9.72 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
9.72 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
15.96 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
15.96 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
15.96 | 16835633 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
3.54 | 11874814 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.32 | 21441931 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
5.09 | 15451039 15451040 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.44 | 15955085 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
19.65 | 15504547 16511603 17963324 |
MESH:D000740 |
Anemia |
|
Phenacetin |
19.65 | 2444515 |
MESH:D000740 |
Anemia |
|
phenylhydrazine |
19.65 | 2444515 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
19.65 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Phenacetin |
10.37 | 1949026 17082564 17698508 |
MESH:D000743 |
Anemia, Hemolytic |
|
phenylhydrazine |
10.37 | 17698508 17084956 17082564 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.61 | 10982225 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.59 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
3.83 | 11141031 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
4.37 | 15014928 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
2.94 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.21 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.28 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.44 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.18 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
14.08 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
14.08 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
14.08 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.56 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.62 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.47 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.36 | 15867366 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.66 | 11985600 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.61 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Ascorbic Acid |
6.77 | 16443354 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
6.77 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
6.77 | 18234424 12006526 11325840 18323546 17388661 16978400 17020986 15093573 15136595 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
6.77 | 16595493 16096432 15692762 18695136 11325840 16264153 16826403 15567936 16322301 19526202 15993339 15939500 17426702 15136595 18234424 15668708 16115903 18628466 17369602 15634643 16935488 18382427 17983394 15994142 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
6.77 | 17289903 18497071 14630087 16675129 17261762 19861407 12948864 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
6.77 | 15136595 16595493 19217205 18608205 18357371 16110121 16557594 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
6.77 | 16873071 17200150 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
6.77 | 11325840 16244791 16115903 16273361 18234424 15136595 18223236 18323546 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
6.77 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
6.77 | 16443354 16873071 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.36 | 16813970 |
MESH:D002056 |
Burns |
|
Ethanol |
4.43 | 16374292 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.23 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
11.58 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
11.58 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
7.59 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.59 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.93 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
22.17 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
22.17 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
22.17 | 16234567 18059187 17876044 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
22.17 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
22.17 | 15289165 15763234 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
22.17 | 17045692 18930000 16332177 16799960 17088986 17971768 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
22.17 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
22.17 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
22.17 | 1701930 20935162 20007298 6705139 17173139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
22.17 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.76 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.66 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
10.28 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
10.28 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
10.28 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
7.20 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
7.20 | 16757204 17066447 18986760 16280240 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.20 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
6.43 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.43 | 16120746 18670907 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.38 | 17974986 17928571 16455267 18627295 16242529 17351982 16278810 16651473 17007740 16364871 17382496 15505089 17924179 16109756 15811867 16731534 16952015 17131338 15792986 17329180 16612575 17308081 15476868 16269455 17519947 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.87 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.15 | 16332659 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
6.78 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
6.78 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.24 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
10.24 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
10.24 | 18566989 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.03 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.36 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.97 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.20 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.20 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.93 | 16461808 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.47 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
13.35 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
13.35 | 12621046 8697196 16354765 15340226 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
13.35 | 9407595 |
MESH:D002972 |
Cleft Palate |
|
triadimefon |
13.35 | 16781842 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.48 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
3.70 | 16340194 17725105 17016597 15001691 17169374 16510598 18772588 17018589 17172411 17287894 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
3.70 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
4.68 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
4.68 | 16303861 16391804 18802399 18288408 18509181 14970324 16524972 17255274 15289873 17016601 17401013 18949393 17454858 17094418 15148649 20501625 18383874 18448328 17695437 17594712 16282729 16331619 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
4.68 | 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Polychlorinated Biphenyls |
4.68 | 15531428 |
MESH:D003139 |
Common Cold |
|
Ascorbic Acid |
5.24 | 17323712 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.87 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
5.25 | 15513904 15451039 11873399 11198716 10194807 19302082 15451040 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
5.25 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
5.25 | 9125849 10589399 9664655 9142499 14991402 17551590 9224671 9211117 8800419 16925845 |
MESH:D019465 |
Craniofacial Abnormalities |
|
triadimefon |
5.25 | 16875885 15834900 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.75 | 16413132 16651033 12388444 12161096 10498854 18710439 16614059 18433785 18372110 12913760 15276878 11948286 15643279 18483878 18093676 16989017 17010015 10700343 17979934 18295254 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.56 | 16733453 |
MESH:D003704 |
Dementia |
|
Polychlorinated Biphenyls |
4.50 | 16140633 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.32 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
3.88 | 10990075 11751995 15331540 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.15 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Ascorbic Acid |
6.88 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
6.88 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.88 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.22 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
8.41 | 11743745 16177239 19420014 11461765 2444490 18071297 17562736 19416960 19164858 11834606 10774834 16227642 14550746 15968718 19370779 16109766 11739529 14986274 12392966 16081117 15619225 19739265 12540782 14725611 18713872 16781746 19923254 12958197 12594235 19085960 12153990 17522070 16393943 11421492 16485898 11287661 12705907 10915739 11529661 10663392 17906064 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
8.41 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
8.41 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.41 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.87 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.56 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.56 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.79 | 1851702 |
MESH:C538011 |
Eales disease |
|
Ascorbic Acid |
5.24 | 9068938 |
MESH:D004487 |
Edema |
|
pirinixic acid |
5.87 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.87 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.17 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.17 | 18230668 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.36 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
16.59 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
16.59 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
16.59 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
16.59 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.82 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.93 | 18037988 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
3.99 | 11006010 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.88 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.64 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.77 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.35 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.03 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.79 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
9.95 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
9.95 | 16704527 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
9.95 | 16481741 15173087 17638652 16337965 16785472 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
9.95 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.28 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.28 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
11.94 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
11.94 | 19236843 18620774 16409862 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
11.94 | 19236843 20131406 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.43 | 17920746 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
5.07 | 16946407 15451040 15513904 10194807 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.23 | 11858732 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.36 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
13.42 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.42 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
13.42 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
10.36 | 16983495 |
MESH:D005756 |
Gastritis |
|
Ethanol |
10.36 | 15046732 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.99 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
11.08 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
11.08 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
11.08 | 17312396 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.78 | 16145905 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.28 | 11389073 |
MESH:D005911 |
Gliosis |
|
Paraquat |
4.93 | 11124998 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.36 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.81 | 16376943 15172196 11014644 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
12.10 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
12.10 | 15162350 18337622 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
12.10 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.93 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Ascorbic Acid |
10.55 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.55 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.55 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.33 | 14766674 17888722 16879835 18674790 17875725 16330681 18006777 16144979 16244372 16707910 16495754 12587719 16244371 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.59 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.59 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.70 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.19 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.06 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.13 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.30 | 14986274 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
24.77 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
24.77 | 19176532 16221962 19772884 18467677 |
MESH:D006529 |
Hepatomegaly |
|
systhane |
24.77 | 17178689 17178688 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
24.77 | 15340226 16120746 12621046 |
MESH:D006529 |
Hepatomegaly |
|
triadimefon |
24.77 | 17178688 17178689 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Ascorbic Acid |
3.40 | 16490937 16863852 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.80 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
7.08 | 17606976 16135485 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
7.08 | 15147373 18501091 17606976 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.52 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.81 | 8697196 16354765 15340226 16959395 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
12.04 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
12.04 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
12.04 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.34 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.99 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.66 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.66 | 18670907 18850075 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.10 | 16076520 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
6.66 | 16517039 7193160 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
6.66 | 4850670 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.75 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
11.46 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
11.46 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
11.46 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.54 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
22.96 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
22.96 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
22.96 | 15992940 17551590 |
MESH:D007569 |
Jaw Abnormalities |
|
triadimefon |
22.96 | 15992940 15834900 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.21 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
13.35 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
13.35 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
13.35 | 15699352 16775033 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
13.35 | 15618244 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
3.95 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.34 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
11.34 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
11.34 | 16985049 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
3.99 | 15451040 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
9.93 | 10602166 |
MESH:D007938 |
Leukemia |
|
Genistein |
9.93 | 17468513 18980019 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
9.93 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.93 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.40 | 18587576 17802794 17296974 17008537 18172266 17658394 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
3.92 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.49 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.04 | 19850784 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.01 | 17361223 16788101 17107899 17649720 19075265 16331271 19642359 16935935 17294898 12679006 16823087 16140955 17339181 17368321 16891316 17506722 9834237 19029980 17712046 15748426 19035177 17301526 16766008 19225113 17217047 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.74 | 10052129 11830472 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
7.78 | 17676605 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
7.78 | 9224671 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.61 | 17353645 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
6.43 | 15289165 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
6.43 | 21047994 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.87 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
10.47 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
10.47 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
10.47 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
10.47 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
10.47 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
10.47 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
10.47 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
6.27 | 12969438 16611625 19460945 11587558 19014921 12587719 19784758 16610002 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
6.27 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
triadimefon |
6.27 | 19363144 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.43 | 17347304 17207112 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.04 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
16.85 | 15113037 16603448 17045692 18383874 |
MESH:D008113 |
Liver Neoplasms |
|
Methapyrilene |
16.85 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
16.85 | 19812893 8742319 15975961 19073162 19482888 21047994 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
16.85 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
16.85 | 16984957 |
MESH:D008113 |
Liver Neoplasms |
|
triadimefon |
16.85 | 19028983 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Ascorbic Acid |
26.12 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
26.12 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
26.12 | 18308698 1399818 6150874 2563599 17172636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Polychlorinated Biphenyls |
26.12 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
systhane |
26.12 | 17178689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
26.12 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
triadimefon |
26.12 | 17178689 |
MESH:D008171 |
Lung Diseases |
|
Ascorbic Acid |
3.80 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
Ascorbic Acid |
4.67 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
4.67 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
4.67 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.67 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.56 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
7.34 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.34 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.38 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
13.60 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
13.60 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
13.60 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.34 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
9.20 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
9.20 | 11807958 11408345 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
9.20 | 14578162 12929590 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.25 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.70 | 17453147 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
4.98 | 16827129 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
4.98 | 12040289 16342250 12025231 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
4.98 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
10.08 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
10.08 | 16388313 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.97 | 15451040 18411066 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.20 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
2.97 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.56 | 16801185 |
MESH:D008708 |
Methemoglobinemia |
|
Phenacetin |
4.74 | 4834387 1949026 3537620 16296465 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.29 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.46 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.56 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
3.53 | 14749477 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.28 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
2.95 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
8.93 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
8.93 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
8.93 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.84 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
13.17 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
13.17 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
13.17 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.25 | 17484760 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.83 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
5.83 | 15867366 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
10.96 | 18854779 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
10.96 | 18239605 18600527 16928823 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
10.96 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
10.96 | 16594593 16946489 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.50 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.54 | 16636307 16899518 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.21 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
8.66 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
8.66 | 15640375 16889571 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
8.07 | 16893418 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
8.07 | 18619942 17356569 15790535 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
28.40 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
28.40 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
28.40 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
28.40 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
28.40 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
2.91 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
6.83 | 8761367 15176712 16115947 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
6.83 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.69 | 18514411 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.66 | 8761367 12837982 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.29 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.11 | 8291058 |
MESH:D009765 |
Obesity |
|
Ascorbic Acid |
4.55 | 17217161 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.55 | 20558911 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.48 | 16517039 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.75 | 15867366 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.13 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.11 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
3.87 | 16169203 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.93 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.76 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.72 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
10.72 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
10.72 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
10.72 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
10.23 | 16870215 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
10.23 | 12161096 18093676 |
MESH:D010146 |
Pain |
|
Tretinoin |
10.23 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
15.45 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
15.45 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
15.45 | 15113037 16929163 16500647 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
15.45 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
15.45 | 15976015 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
8.34 | 16510128 12911755 15451049 11445065 11124998 15824117 16140633 11181820 |
MESH:D010300 |
Parkinson Disease |
|
Polychlorinated Biphenyls |
8.34 | 16702228 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
8.34 | 16412576 15451049 18619942 11445065 16140633 19232380 18191903 11535288 19114014 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
4.21 | 16190885 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
3.88 | 15927086 18197244 15574749 15795934 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.02 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.93 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.93 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
4.22 | 12504350 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.34 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.33 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
8.33 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.68 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
8.75 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.75 | 11118676 11896295 11399792 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
9.87 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.87 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.41 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.41 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.41 | 16888761 15749863 18437689 16868541 15897917 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.41 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.41 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.41 | 16925846 15378649 15256057 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
2.41 | 17172428 16356831 16729912 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Polychlorinated Biphenyls |
2.41 | 15721890 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.39 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.26 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.15 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.56 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.56 | 10548101 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Ascorbic Acid |
5.10 | 14606601 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
5.71 | 16636934 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
5.71 | 17997886 16324872 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.82 | 18722050 16160472 18286688 15538739 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.00 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.28 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
3.70 | 11700416 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
3.83 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.70 | 16458197 |
MESH:D012174 |
Retinitis Pigmentosa |
|
Ascorbic Acid |
3.25 | 16849425 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.89 | 16283617 16116481 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.79 | 17710206 15675481 15625365 18313854 16767912 17203757 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.02 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.56 | 17846226 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.61 | 16636934 |
MESH:D012640 |
Seizures |
|
Ethanol |
5.65 | 9754883 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
5.65 | 11442880 3137016 4039156 16876388 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.59 | 6407741 |
MESH:D012871 |
Skin Diseases |
|
Ascorbic Acid |
3.15 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
12.69 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
12.69 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.69 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
12.69 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.34 | 17203757 15625365 16767912 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.28 | 16517039 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
4.59 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
4.59 | 17522103 17172411 18396642 19084572 15786421 18567086 16424979 17498489 19015929 16951190 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
4.59 | 18396642 18506536 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.59 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Ascorbic Acid |
7.02 | 18726076 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
7.02 | 9211565 16755016 9562338 11906479 17189318 17918041 |
MESH:D020521 |
Stroke |
|
Ascorbic Acid |
4.11 | 16403987 16517955 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.76 | 16045194 16684133 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
4.06 | 9754883 |
MESH:D013436 |
Sulfhemoglobinemia |
|
Phenacetin |
6.32 | 978859 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.83 | 12837982 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.58 | 16930453 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.67 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
15.76 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
15.76 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
15.76 | 16026305 17045167 |
MESH:D013964 |
Thyroid Neoplasms |
|
triadimefon |
15.76 | 17178689 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.45 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
9.17 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
9.17 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.09 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
8.14 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.14 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Phenacetin |
8.14 | 11144890 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.77 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
8.79 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
8.79 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.78 | 14652134 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.38 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.75 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.36 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.00 | 17334414 17638931 17678736 16364871 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.84 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.02 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.78 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.21 | 17120751 |